サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1499443

医薬品スクリーニング市場：製品タイプ別、サンプルタイプ別、エンドユーザー別-2024～2030年の世界予測

Drug Screening Market by Product (Consumables, Instruments, Services), Sample Type (Breath Samples, Hair Samples, Oral Fluid Samples), End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
医薬品スクリーニング市場：製品タイプ別、サンプルタイプ別、エンドユーザー別-2024～2030年の世界予測
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品スクリーニング市場規模は、2023年に86億6,000万米ドルと推定され、2024年には98億9,000万米ドルに達し、CAGR 14.42%で2030年には222億5,000万米ドルに達すると予測されます。

医薬品スクリーニングとは、尿、血液、毛髪、唾液などの生体サンプルを検査し、違法薬物や処方薬物、その代謝物の存在を特定するプロセスです。このプロセスは、雇用、刑事司法、スポーツ、依存症の治療など、さまざまな場面で一般的に使用され、個人が薬物政策を遵守していること、または禁止物質がないことを確認します。職場における安全性とコンプライアンスの向上、処方薬と非処方薬の世界の消費量の増加、薬物検査を義務付ける政府による厳格な規制と組織の方針が大きな推進力となっています。しかし、高度な検査技術には高いコストがかかり、薬物検出窓にはばらつきがあるため、採用が妨げられる可能性があります。とはいえ、より高感度かつ迅速な検査の開拓と、モバイルおよびオンサイトの薬物検査サービスに対するニーズの高まりは、市場成長の潜在的機会を生み出すと予想されます。

主な市場の統計
基準年[2023］ 86億6,000万米ドル
予測年［2024] 98億9,000万米ドル
予測年 [2030] 222億5,000万米ドル
CAGR（%） 14.42%

地域別インサイト

アジア太平洋地域は、職場の安全性と効率性、公衆衛生に対する意識の高まりにより、医薬品スクリーニングで大幅な成長を遂げています。APAC諸国は多様な人口を抱え、薬物乱用の割合も様々であるため、薬物検査サービスの必要性は地域によって異なります。政府機関は薬物乱用を抑制するための取り組みを進めており、医薬品スクリーニング機器やサービスに対するニーズが高まっています。アメリカ地域は、厳格な規制要件と職場安全規制の施行により、医薬品スクリーニングの発展市場の一つとなっています。オピオイド危機により、薬物検査への注目がさらに高まっています。南北アメリカ地域では、薬物検査手法やキットの技術革新を反映し、特許登録が進化し続けています。EU諸国は公衆衛生と職場の安全性に強く注目しており、医薬品スクリーニングの実践を管理する厳格な法律があります。データ保護規制は職場の薬物検査管理にも影響を与えます。麻薬取締法が厳しい中東諸国では、医薬品スクリーニングの市場が変動しており、しばしば政府の政策によって義務付けられています。アフリカの医薬品スクリーニング市場は台頭しつつあり、医薬品スクリーニングに対する認識とニーズは、主に公衆衛生キャンペーンと国際的な職場安全基準の影響を受けて高まっています。欧州諸国は研究開発に多大な投資を行っており、その結果、高い精度と信頼性基準を満たす高度な医薬品スクリーニング技術が開発されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、医薬品スクリーニング市場におけるベンダーのポジショニングを評価するために不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront（F）、Pathfinder（P）、Niche（N）、Vital（V）に分類されます。

市場シェア分析

市場シェア分析は、医薬品スクリーニング市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、医薬品スクリーニング市場における現在の立ち位置を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で娯楽目的および処方薬の乱用が急増
      • 職場の安全性とコンプライアンスの向上
      • 薬物検査を義務付ける政府による規制や組織の方針
    • 抑制要因
      • 医薬品スクリーニングの結果を操作する可能性
    • 機会
      • 革新的な医薬品スクリーニング技術とキットの開発
      • モバイルおよびオンサイトの薬物検査サービスに対する需要の増加
    • 課題
      • 経済全体にわたる医薬品スクリーニングの標準的な規制枠組みの欠如
  • 市場セグメンテーション分析
    • 製品：非侵襲的で迅速な結果を提供する口腔液検査装置の利用が急増
    • エンドユーザー：薬物治療センターにおける医薬品スクリーニングの重要な利用
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 医薬品スクリーニング市場：製品別

  • 消耗品
  • 機器
  • サービス

第7章 医薬品スクリーニング市場サンプルタイプ別

  • 呼気サンプル
  • 毛髪サンプル
  • 口腔液サンプル
  • 尿サンプル

第8章 医薬品スクリーニング市場：エンドユーザー別

  • 刑事司法制度と法執行機関
  • 薬物検査研究所
  • 薬物治療センター
  • 病院
  • 個人ユーザー
  • 疼痛管理センター
  • 学校と大学
  • 職場

第9章 南北アメリカの医薬品スクリーニング市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の医薬品スクリーニング市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの医薬品スクリーニング市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • 革新的なパートナーシップが仮想医薬品スクリーニングプラットフォームを立ち上げ
    • Accurate Backgroundの高度な薬物および健康スクリーニングサービスの開始
    • bioXcelerateがAIを活用したスクリーニングツールで創薬に革命を起こす
  • 戦略分析と提言

第13章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. DRUG SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DRUG SCREENING MARKET DYNAMICS
  • FIGURE 7. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG SCREENING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL DRUG SCREENING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG SCREENING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL DRUG SCREENING MARKET SIZE, BY ASSAY KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG SCREENING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL DRUG SCREENING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG SCREENING MARKET SIZE, BY FUEL-CELL BREATHALYZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL DRUG SCREENING MARKET SIZE, BY FUEL-CELL BREATHALYZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL DRUG SCREENING MARKET SIZE, BY SEMICONDUCTOR BREATHALYZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL DRUG SCREENING MARKET SIZE, BY SEMICONDUCTOR BREATHALYZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL DRUG SCREENING MARKET SIZE, BY DIP CARDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL DRUG SCREENING MARKET SIZE, BY DIP CARDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CASSETTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CASSETTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CUPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING CUPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL DRUG SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL DRUG SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL DRUG SCREENING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL DRUG SCREENING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL DRUG SCREENING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL DRUG SCREENING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL DRUG SCREENING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL DRUG SCREENING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL DRUG SCREENING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL DRUG SCREENING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL DRUG SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL DRUG SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL DRUG SCREENING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL DRUG SCREENING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL DRUG SCREENING MARKET SIZE, BY SCHOOLS & COLLEGES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL DRUG SCREENING MARKET SIZE, BY SCHOOLS & COLLEGES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL DRUG SCREENING MARKET SIZE, BY WORKPLACES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL DRUG SCREENING MARKET SIZE, BY WORKPLACES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 91. AMERICAS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 92. AMERICAS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 93. AMERICAS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 94. AMERICAS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 95. AMERICAS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 96. AMERICAS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 97. AMERICAS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 98. AMERICAS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 99. AMERICAS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. AMERICAS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. AMERICAS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 102. AMERICAS DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 103. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 104. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 105. ARGENTINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. ARGENTINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. ARGENTINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 108. ARGENTINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 109. ARGENTINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 110. ARGENTINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 111. ARGENTINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 112. ARGENTINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 113. ARGENTINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 114. ARGENTINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 115. ARGENTINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 116. ARGENTINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 117. ARGENTINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 118. ARGENTINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 119. ARGENTINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. ARGENTINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. ARGENTINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 122. ARGENTINA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 123. BRAZIL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. BRAZIL DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. BRAZIL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 126. BRAZIL DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 127. BRAZIL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 128. BRAZIL DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 129. BRAZIL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 130. BRAZIL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 131. BRAZIL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 132. BRAZIL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 133. BRAZIL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 134. BRAZIL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 135. BRAZIL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 136. BRAZIL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 137. BRAZIL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. BRAZIL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. BRAZIL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 140. BRAZIL DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 141. CANADA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. CANADA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. CANADA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 144. CANADA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 145. CANADA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 146. CANADA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 147. CANADA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 148. CANADA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 149. CANADA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 150. CANADA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 151. CANADA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 152. CANADA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 153. CANADA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 154. CANADA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 155. CANADA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. CANADA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. CANADA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 158. CANADA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 159. MEXICO DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 160. MEXICO DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 161. MEXICO DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 162. MEXICO DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 163. MEXICO DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 164. MEXICO DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 165. MEXICO DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 166. MEXICO DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 167. MEXICO DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 168. MEXICO DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 169. MEXICO DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 170. MEXICO DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 171. MEXICO DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 172. MEXICO DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 173. MEXICO DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. MEXICO DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. MEXICO DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 176. MEXICO DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 177. UNITED STATES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. UNITED STATES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. UNITED STATES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 180. UNITED STATES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 181. UNITED STATES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 182. UNITED STATES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 183. UNITED STATES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 184. UNITED STATES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 185. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 186. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 187. UNITED STATES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 188. UNITED STATES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 191. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. UNITED STATES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. UNITED STATES DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 196. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 217. AUSTRALIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. AUSTRALIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. AUSTRALIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 220. AUSTRALIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 221. AUSTRALIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 222. AUSTRALIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 223. AUSTRALIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 224. AUSTRALIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 225. AUSTRALIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 226. AUSTRALIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 227. AUSTRALIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 228. AUSTRALIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 229. AUSTRALIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 230. AUSTRALIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 231. AUSTRALIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. AUSTRALIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. AUSTRALIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 234. AUSTRALIA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 235. CHINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. CHINA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. CHINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 238. CHINA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 239. CHINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 240. CHINA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 241. CHINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 242. CHINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 243. CHINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 244. CHINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 245. CHINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 246. CHINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 247. CHINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 248. CHINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 249. CHINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. CHINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. CHINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. CHINA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. INDIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. INDIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. INDIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 256. INDIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 257. INDIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 258. INDIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 259. INDIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 260. INDIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 261. INDIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 262. INDIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 263. INDIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 264. INDIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 265. INDIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 266. INDIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 267. INDIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. INDIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. INDIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 270. INDIA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 271. INDONESIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. INDONESIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. INDONESIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 274. INDONESIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 275. INDONESIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 276. INDONESIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 277. INDONESIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 278. INDONESIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 279. INDONESIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 280. INDONESIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 281. INDONESIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 282. INDONESIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 283. INDONESIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 284. INDONESIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 285. INDONESIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. INDONESIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. INDONESIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 288. INDONESIA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 289. JAPAN DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. JAPAN DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. JAPAN DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 292. JAPAN DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 293. JAPAN DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 294. JAPAN DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 295. JAPAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 296. JAPAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 297. JAPAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 298. JAPAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 299. JAPAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 300. JAPAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 301. JAPAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 302. JAPAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 303. JAPAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. JAPAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. JAPAN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 306. JAPAN DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 307. MALAYSIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. MALAYSIA DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. MALAYSIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 310. MALAYSIA DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 311. MALAYSIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 312. MALAYSIA DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 313. MALAYSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 314. MALAYSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 315. MALAYSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 316. MALAYSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 317. MALAYSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 318. MALAYSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 319. MALAYSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 320. MALAYSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 321. MALAYSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. MALAYSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. MALAYSIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 324. MALAYSIA DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 325. PHILIPPINES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 326. PHILIPPINES DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 327. PHILIPPINES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 328. PHILIPPINES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 329. PHILIPPINES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 330. PHILIPPINES DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 331. PHILIPPINES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 332. PHILIPPINES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 333. PHILIPPINES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 334. PHILIPPINES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 335. PHILIPPINES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 336. PHILIPPINES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 337. PHILIPPINES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 338. PHILIPPINES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 339. PHILIPPINES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. PHILIPPINES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. PHILIPPINES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 342. PHILIPPINES DRUG SCREENING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 343. SINGAPORE DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. SINGAPORE DRUG SCREENING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. SINGAPORE DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 346. SINGAPORE DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 347. SINGAPORE DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 348. SINGAPORE DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 349. SINGAPORE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 350. SINGAPORE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 351. SINGAPORE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2023 (USD MILLION)
  • TABLE 352. SINGAPORE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2024-2030 (USD MILLION)
  • TABLE 353. SINGAPORE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 354. SINGAPORE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 355. SINGAPORE DRUG SCREENING MARKE
目次
Product Code: MRR-DD6333AE5B92

[199 Pages Report] The Drug Screening Market size was estimated at USD 8.66 billion in 2023 and expected to reach USD 9.89 billion in 2024, at a CAGR 14.42% to reach USD 22.25 billion by 2030.

Drug screening is the process of checking biological samples, such as urine, blood, hair, or saliva, to identify the existence of illegal or prescription drugs or their metabolites. This process is commonly used in various contexts, including employment, criminal justice, sports, and treatment of addiction, ensuring individuals are compliant with drug policies or are free from prohibited substances. Increased safety and compliance in workplaces, increasing consumption of both prescription and non-prescription drugs worldwide, and strict regulations by governments and organizational policies mandating drug testing are significant drivers. However, the high costs of advanced testing technologies and variability in drug detection windows can deter adoption. Nevertheless, the development of more sensitive and faster tests and the growing need for mobile and on-site drug testing services are expected to create potential opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 8.66 billion
Estimated Year [2024] USD 9.89 billion
Forecast Year [2030] USD 22.25 billion
CAGR (%) 14.42%

Regional Insights

The Asia-Pacific region has seen substantial growth in drug screening due to increasing awareness about the safety and efficiency of workplaces and public health. APAC countries have diverse populations and exhibit varying rates of substance abuse, which influences the need for drug testing services differently across the region. Government agencies have advanced their efforts in curbing drug abuse, translating into a higher need for drug screening devices and services. The Americas region is one of the evolved markets for drug screening due to strict regulatory requirements and the enforcement of workplace safety regulations. The opioid crisis has further heightened the focus on drug testing. The Americas region continues evolving in patent registrations, reflecting ongoing drug testing methodologies and kit innovations. EU countries focus strongly on public health and workplace safety, with rigorous laws governing drug screening practices. The data protection regulation also impacts the administration of workplace drug testing. With stringent anti-drug laws, countries in the Middle East have a variable market for drug screening, often mandated by government policies. Africa's drug screening market is emerging, with an increasing awareness and need for drug screening primarily influenced by public health campaigns and international workplace safety standards. European countries invest significantly in research and development, which has led to advanced drug screening technologies designed to meet high accuracy and reliability standards.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Drug Screening Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Surge in both recreational and prescription drug misuse globally
      • Increased safety and compliance in workplaces
      • Regulations by governments and organizational policies mandating drug testing
    • Market Restraints
      • Possibility of manipulation of drug screening results
    • Market Opportunities
      • Development of innovative drug screening technologies and kits
      • Growing demand for mobile and on-site drug testing services
    • Market Challenges
      • Lack of standard regulatory framework for drug screening across economies
  • Market Segmentation Analysis
    • Product: Proliferating utilization of oral fluid testing devices providing non-invasive quick results
    • End User: Significant utilization of the drug screening in the drug treatment centers
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Drug Screening Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Drug Screening Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Innovative Partnership Launches Virtual Drug Screening Platform

eMed, a digital health company, partnered with i3Screen, an established provider of drug screening solutions, to introduce virtual drug testing services. This new platform is designed to facilitate remote drug screening, utilizing eMed's patented technology to ensure the integrity and confidentiality of the testing process. The service is tailored for employers and organizations looking to implement drug testing efficiently while minimizing the need for physical interactions. This partnership enhances the accessibility and effectiveness of drug testing programs and aligns with current trends toward more digital and remote healthcare solutions. [Published On: 2024-05-15]

Launch of Accurate Background's Advanced Drug and Health Screening Services

Accurate Background, a provider of background and identity services, has recently expanded its offerings by launching a new, enhanced drug and health screening service. This service is designed to accommodate the growing demand for efficient and comprehensive employee screening processes. With this advancement, the company introduces a streamlined platform integrating enhanced drug testing methods with robust health screening capabilities. Employers benefit from this service as it provides a more efficient way to conduct pre-employment health assessments, enabling faster and more informed hiring decisions. This initiative underscores Accurate Background's commitment to innovating within the industry and enhances its ability to support employers in maintaining a safe and compliant workplace. [Published On: 2024-04-04]

bioXcelerate Revolutionizes Drug Discovery with AI-Powered Screening Tool

bioXcelerate announced the launch of a cutting-edge artificial intelligence (AI) tool designed to expedite the drug discovery process significantly. This innovative technology aims to streamline the early stages of drug development by enhancing the screening of chemical compounds and expediting the identification of promising drug candidates. By leveraging AI, bioXcelerate anticipates reducing the time and costs traditionally associated with these phases, potentially accelerating the timeline for bringing new drugs to market. This breakthrough is instrumental in ushering in a new era of faster, more efficient drug discovery, particularly beneficial in addressing rapidly evolving global health challenges. [Published On: 2024-03-24]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Drug Screening Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Drug Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuSourceHR, Inc., ACM Global Laboratories, Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Cordant Health Solutions, Danaher Corporation, Dragerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Intoximeters, Inc., Laboratory Corporation of America Holdings, Lifeloc Technologies, Inc., Merck KGaA, Omega Laboratories, Inc. by Juno Pharmaceuticals Corp., OraSure Technologies, Inc., Pfizer Inc., Premier Biotech, LLC, Psychemedics Corporation, Quest Diagnostics Incorporated, Sartorius AG, Securetec Detektions-Systeme AG, Shimadzu Corporation, Siemens AG, Thermo Fisher Scientific Inc., and United States Drug Testing Laboratories, Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
      • Assay Kits
      • Calibrators & Controls
      • Sample Collection Tubes
    • Instruments
      • Analytical Instruments
        • Breathalyzers
        • Fuel-Cell Breathalyzers
  • Semiconductor Breathalyzers
        • Chromatography Instruments
        • Immunoassay Analyzers
      • Rapid Testing Devices
        • Oral Fluid Testing Devices
        • Urine Testing Devices
        • Dip Cards
  • Drug Testing Cassettes
  • Drug Testing Cups
  • Services
  • Sample Type
    • Breath Samples
    • Hair Samples
    • Oral Fluid Samples
    • Urine Samples
  • End User
    • Criminal Justice Systems & Law Enforcement Agencies
    • Drug Testing Laboratories
    • Drug Treatment Centers
    • Hospitals
    • Individual Users
    • Pain Management Centers
    • Schools & Colleges
    • Workplaces
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in both recreational and prescription drug misuse globally
      • 5.1.1.2. Increased safety and compliance in workplaces
      • 5.1.1.3. Regulations by governments and organizational policies mandating drug testing
    • 5.1.2. Restraints
      • 5.1.2.1. Possibility of manipulation of drug screening results
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of innovative drug screening technologies and kits
      • 5.1.3.2. Growing demand for mobile and on-site drug testing services
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standard regulatory framework for drug screening across economies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Proliferating utilization of oral fluid testing devices providing non-invasive quick results
    • 5.2.2. End User: Significant utilization of the drug screening in the drug treatment centers
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Drug Screening Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Services

7. Drug Screening Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Breath Samples
  • 7.3. Hair Samples
  • 7.4. Oral Fluid Samples
  • 7.5. Urine Samples

8. Drug Screening Market, by End User

  • 8.1. Introduction
  • 8.2. Criminal Justice Systems & Law Enforcement Agencies
  • 8.3. Drug Testing Laboratories
  • 8.4. Drug Treatment Centers
  • 8.5. Hospitals
  • 8.6. Individual Users
  • 8.7. Pain Management Centers
  • 8.8. Schools & Colleges
  • 8.9. Workplaces

9. Americas Drug Screening Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Screening Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Screening Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Innovative Partnership Launches Virtual Drug Screening Platform
    • 12.3.2. Launch of Accurate Background's Advanced Drug and Health Screening Services
    • 12.3.3. bioXcelerate Revolutionizes Drug Discovery with AI-Powered Screening Tool
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio